Goldman Sachs
OXFD

Goldman Sachs’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Goldman Sachs’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28,690
Closed -$336K – 5839
2020
Q3 		$336K Buy
+28,690
New +$381K ﹤0.01% 4675
2020
Q1 		– Sell
-10,970
Closed -$182K – 5683
2019
Q4 		$182K Sell
10,970
-2,002
-15% -$32.5K ﹤0.01% 4918
2019
Q3 		$216K Sell
12,972
-141,835
-92% -$1.96M ﹤0.01% 4802
2019
Q2 		$2.13M Buy
154,807
+139,417
+906% +$2.13M ﹤0.01% 3498
2019
Q1 		$265K Sell
15,390
-152
-1% -$2.4K ﹤0.01% 4683
2018
Q4 		$199K Sell
15,542
-14,207
-48% -$215K ﹤0.01% 4834
2018
Q3 		$483K Sell
29,749
-33,431
-53% -$478K ﹤0.01% 4443
2018
Q2 		$814K Buy
63,180
+31,840
+102% +$430K ﹤0.01% 4215
2018
Q1 		$390K Buy
31,340
+20,598
+192% +$251K ﹤0.01% 4639
2017
Q4 		$150K Sell
10,742
-2,854
-21% -$41.8K ﹤0.01% 5560
2017
Q3 		$228K Sell
13,596
-19,627
-59% -$319K ﹤0.01% 5676
2017
Q2 		$559K Sell
33,223
-2,455
-7% -$36.7K ﹤0.01% 4999
2017
Q1 		$553K Buy
35,678
+22,704
+175% +$324K ﹤0.01% 4927
2016
Q4 		$194K Sell
12,974
-4,682
-27% -$65.7K ﹤0.01% 5788
2016
Q3 		$222K Buy
+17,656
New +$177K ﹤0.01% 5741
2016
Q2 		– Sell
-13,244
Closed -$131K – 7354
2016
Q1 		$131K Buy
+13,244
New +$136K ﹤0.01% 5923

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs's OXFD Position: Q4 2020 in Review

Goldman Sachs sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 28,690 shares — an estimated $336K sold.

Goldman Sachs first reported a position in OXFD in Q1 2016 and held it in 16 quarters. The position peaked at $2.13M in Q2 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • Goldman Sachs reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 28,690 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $336K.
  • Goldman Sachs first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2016 and held it in 16 quarters.
  • Goldman Sachs's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.13M in Q2 2019.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.